Depression is a common and disabling disorder that affects people of all ages and 10% of those older than 65 years. Current strategies to decrease the personal and societal burden of depression in older age rely on the management of people with depression or of those at risk, but benefits have been limited and data remain scant.
INTRODUCTION
Depression is a common mental disorder that affects people of all ages and about 10% of those older than 60 years living in the community [1, 2] . Current estimates indicate that depression is the leading cause of years of life lost because of disability in both high-income and middle-income countries [3] , which may seem surprising given that effective treatment is widely available. This apparent contradiction can be partly explained by suboptimal access of patients with depression to services [4, 5] and to the limited efficacy of standard treatments [6] [7] [8] . Hence, there are two options to decrease the growing public health burden associated with depression worldwide: prevent the development of depression in people at risk (i.e., reduce the incidence of depression) and improve access to services and the effectiveness of antidepressant treatments (i.e., decrease the prevalence of depression).
CAN WE PREVENT DEPRESSION IN LATER LIFE?
Ideally, effective preventive strategies should successfully target factors that are causally related to depression. The problem is that establishing causality in psychiatry is not a simple task, even though tentative guidelines have been available for nearly 5 decades [9] . Recent pragmatic approaches to the prevention of depression have focussed on older people with symptoms of depression that do not reach threshold for the diagnosis of a depressive disorder [10] , the so-called 'indicated prevention' [11] . A good illustration of such a study is the Preventive Intervention for Frail Elderly, the PIKO project. Van't Veer-Tazelaar et al. [12] selected a sample of 170 adults aged 75 years or over who scored 16 or more on the Center for Epidemiologic Studies Depression Scale (CES-D) but did not fulfil DSM-IV criteria for a depressive or anxiety disorder at the time of assessment or during the preceding 12 months. The investigators implemented a stepped care intervention that consisted of 'watchful waiting' for the first 3 months, bibliotherapy (if subsequent CES-D !16), followed by problemsolving therapy, and, lastly, treatment with antidepressant medications. The relative risk of a depressive or anxiety disorder in the intervention compared with the usual care control group was 0.49 [95% confidence interval (CI) ¼ 0.24-0.98] after 12 months. Four participants met criteria for a depressive disorder, three for an anxiety disorder, and two for mixed anxiety and depression in the intervention group compared with ten cases of depressive disorder, five of anxiety and five mixed states in the usual care group. However, there was no statistically significant difference between the groups when the outcome of the study was limited to depression. In addition, dropout was higher in the intervention than in the usual care group (24 of 86 vs. 8 of 84; x 2 ¼ 3.68, P ¼ 0.002), suggesting the existence of problems with the acceptability of the intervention amongst participants.
Another example of 'indicated prevention' was carried out in Australia and involved 909 people aged 60-74 years [13] . Participants with a score of 16 or more on the Kessler Distress 10-scale (K10) were randomly assigned to treatment with folic acid (400 mg/day) plus vitamin B12 (100 mg/day), physical activity, mental health literacy, or control activities (placebo tablets, nutrition promotion, and pain management) in a crossed 2 Â 2 Â 2 factorial design. By the end of the 24 months of treatment, there was no evidence that the use of B vitamins or physical activity decreased the severity of depressive symptoms (measured with the Patient Health Questionnaire, PHQ-9), although a beneficial effect of literacy during the initial 6 weeks of the intervention was noticed, but not sustained. Of note, the intervention was delivered by post and via telephone contacts.
Other studies have targeted populations at high risk of depression, such as poststroke patients, using an approach commonly known as 'selective prevention'. Summarizing the findings of these studies has proven difficult because of the great heterogeneity of the populations under investigation, the interventions used, and the varying follow-up times [14] . Nonetheless, some trials have found that the use of antidepressants or problem-solving therapy reduces the risk of depression over a period of 12 months in poststroke patients [15] , whilst others have found no benefit associated with active treatment [16] . A secondary analysis of data from a randomized, placebo-controlled trial designed to reduce the risk of cardiovascular events found that poststroke patients treated with folate, B12, and B6 (mean age 63 years) had 50% lower hazard of developing depression during the 7 years of treatment than those treated with placebo, although the authors acknowledged that confounding and bias could have contributed to the results [17 & ]. A recent review of indicated or selective depression prevention trials across the lifespan reported data on 33 trials, most of which used cognitive behavioural or problem-solving therapies as the active intervention [18] . The authors found an overall benefit of the interventions (about 25% risk reduction compared with control interventions), although the nonindependence of some studies was not taken into account in the analyses (i.e., trials with more than one intervention group were treated as separate studies). In addition, there was some evidence of publication bias, which creates uncertainty regarding the validity of the summary findings.
Other approaches used with the aim of reducing the prevalence of depression in the community have focussed on improving the identification of people with depression [19-22,23 & ] and on increasing the efficacy and effectiveness of existing management strategies [8, 24] . Screening and case finding are the approaches most frequently employed to identify people with depression in populations at risk, particularly in general practice settings. However, a meta-analysis of 16 randomized trials found that the systematic use of screening instruments or casefinding procedures increased the recognition of
KEY POINTS
Trial evidence shows that collaborative care and stepped-care programs decrease the prevalence of depression in later life by enhancing the treatment response and reducing the incidence of depressive and anxiety disorders in older people with subthreshold depressive symptoms.
Antidepressant medications, some forms of psychotherapy, and use of certain vitamins hold potential to reduce the incidence of clinically significant depressive symptoms in specific populations at high risk for depression, such as poststroke patients, but data remain scant and difficult to generalize.
The management of older adults at risk of depression should include the systematic assessment and management of relevant risk factors, and not be limited to the use of antidepressant medications and psychotherapy.
depression by 27%, but had no obvious effect on the adoption of treatments or the clinical outcome of patients [25] . Similarly, the evidence in support of the use of educational interventions targeting medical practitioners to reduce the prevalence of depression remains inconclusive.
WHAT ARE THE BEST OPTIONS TO TREAT DEPRESSION IN LATER LIFE?
The successful management of older adults with depression is important not only to decrease personal suffering and direct and indirect health burden, but also to decrease the number of people with depression living in the community. In other words, the more people we treat successfully, the fewer people with depression will exist (see Fig. 1) . At an individual level, we should aim to use therapies that have great efficacy and tolerability, so as to increase the odds of remission and compliance with treatment. Pharmacological treatment with antidepressants in later life has proven efficacy compared with placebo [26,27 & ], particularly when used by patients with moderateto-severe illness [23 & ]. Overall, 40-70% of patients experience clinically significant improvement when they use these medications [26] , and there are no compelling data suggesting that a particular medication or group of medications has greater efficacy than others. In addition, and contrary to widespread belief, there is limited hard evidence that older adults tolerate selective serotonin reuptake inhibitors (SSRIs) better than treatment with tricyclic antidepressants [28, 29] .
There are few randomized trials of psychological interventions for older people with depression, and empirical support for their systematic use in clinical practice is weak [30] . There is some evidence that these interventions may mitigate the severity of depressive symptoms (particularly interpersonal psychotherapy) [31] , but concerns remain regarding the generalizability of findings and whether psychological interventions afford additional benefit to patients when compared with antidepressant treatment alone [32, 33] .
Psychosocial interventions have also been used to treat depressive symptoms in later life with or without antidepressants. Older adults with mild-tomoderate symptoms of depression seem to benefit from various forms of treatment such as physical activity, skill training, social activities, and group support, but again data are limited and existing findings are difficult to generalize and implement in clinical practice [34] .
Electroconvulsive therapy (ECT) use is commonly restricted to cases of severe or psychotic depression that are unresponsive to other forms of treatment [35] . However, randomized controlled trials of ECT in later life depression are all but nonexistent [36] , creating uncertainty about how best to justify its use in clinical practice.
Taken together, currently available evidence indicates that antidepressant interventions can reduce the prevalence of depression in later life. However, existing trial data are mostly limited to the healthy young old, and there is a paucity of information about how best to manage those aged 75 years or over or who present with multiple comorbidities. Similarly, further research is required to guide the management of the substantial proportion of older people who fail to respond well to a standard antidepressant medication or to psychotherapy.
IS IT POSSIBLE TO AVOID RELAPSE AND RECURRENCE OF DEPRESSION?
Depression is often the expression of a recurrent disorder, so that avoiding the relapse or recurrence of symptoms is an important approach to reduce the prevalence of depression in older age. It is, therefore, disappointing that only eight small to mediumsized randomized trials have investigated this issue systematically over follow-up periods ranging from 6 to 24 months [37 & ]. They found that a lower proportion of older adults who continued to use antidepressant medication after successful treatment of the index depressive episode experienced recurrence of symptoms compared with those assigned placebo (25 vs. 52%). The number of people needed to treat to avoid a relapse or recurrence was 3.6 (95% CI ¼ 2.8-4.8), which suggests that treatment maintenance should be encouraged beyond the initial successful management of the acute episode. Psychological interventions, such as interpersonal psychotherapy, may be as effective as antidepressant medications in preventing the relapse or recurrence of symptoms [33] , although systematic data on this topic remain sparse.
APPROACHES DESIGNED TO OPTIMIZE THE MANAGEMENT OF DEPRESSION
Ten years ago, Unutzer et al. [38] reported the results of a collaborative care trial designed to improve the health outcomes of older people with depression, the Improving Mood-Promoting Access to Collaborative Treatment study. They recruited over 1800 older adults with major depression or dysthymia who were randomly assigned to usual care or an intervention that included supervised case management, education, support of antidepressant use and brief problem-solving therapy. After 12 months, 45% of patients in the intervention group had improved compared with only 19% of those receiving usual care [odds ratio (OR) ¼ 3.4, 95% CI ¼ 2.7-4.4]. Gains were sustained over a follow-up period of 2 years [39] . Other trials that used collaborative care models to manage older adults with depression treated in primary care settings have reported similarly encouraging results [12, 40, 41 && ], and there is now evidence that people with chronic illnesses can also benefit from treatment [42 && ]. Notwithstanding the fact that the gains associated with this intervention are modest and the costs high [43, 44] , the introduction of collaborative care management represents a concrete step forward in the effort to reduce the prevalence of depression in older age.
More recently, Almeida et al.
[45 & ] reported data from a large cross-sectional study (n > 20 000 people aged 60 years or over) that investigated the contribution of multiple factors to the risk of depression in later life. They created a risk matrix that included demographic, developmental, lifestyle, socioeconomic and clinical risk factors for depression, and suggested that the cumulative stratification of exposures could assign participants to various probabilistic levels of depression that ranged from less than 3% to slightly more than 80%. The novelty of the proposed approach is that such a matrix could potentially be used in clinical practice to guide interventions aiming to reduce the prevalence of depression in older age. For example, a 76-year-old obese gentleman who is a smoker, lost his father at the age of 9 years and received only 2 years of primary school education has a 20-30% probability of experiencing clinically significant depressive symptoms in later life. In this case, if this person were to give up smoking, become more physically active and reduce his BMI to 28, the probability of depression could potentially drop by 20-25% if the risk factors are causally related to depression. The availability of such information offers clear incentives to the patient and the clinician to consider and address relevant factors that are amenable to change and that are likely to produce the greatest reduction in the risk of depression.
Despite the inherent attraction of such an approach, confirmatory longitudinal and trial data are required to test its usefulness in clinical practice.
CONCLUSION
The figure shows various pathways associated with depression that could potentially be targeted to reduce the prevalence of depression in the community. Remission of depression amongst cases and prevention amongst those free of symptoms are the ultimate goal. Until now, our approach has been mostly limited to the management of those with depression and, more recently, people with subthreshold illness. Notwithstanding concrete progress on that front, data on how best to treat and prevent depression in later life remain scant and limited to the effects of antidepressants and some forms of psychotherapy. Future studies may benefit from integrating information about known risk factors for depression into their interventions [45 & ,46 ] with the aim of determining how this might change the outcome of patients and of those at risk.
